Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Dow Jones futures soft, key employment reports loom

Dow Jones futures trade softly, Covid-19 cases continue to climb and a number of key employment data releases loom.

DJIA Source: Bloomberg

Key US market moves at a glance

The Dow Jones Industrial Average (DJIA) struggled to gain much traction on Wednesday – falling 0.30% or 77 points – to finish the session at the 25,734 point mark.

The S&P 500 and Nasdaq Composite by comparison rose during Wednesday's session, with the FANG cohort leading the gains. Facebook, coming off concerns of an ‘ad exodus’ finished the session up 4.62%, Google (Alphabet) traded 1.73% higher, Amazon was up an impressive 4.36%, Apple's stock fell; while the Netflix share price surged 6.72% to finish at US$485 per share.

The Dow’s constituents traded far less evenly on Wednesday, with Pfizer, Walt Disney and Merck all trading higher, while Walgreens Boots Alliance, Exxon Mobil and IBM were the worst performing Dow stocks.

Mind you, even though the Dow finished Wednesday’s session lower, the general atmosphere was one of optimism in US equity markets, after pharmaceutical giant Pfizer and BioNTech announced positive results from early-stage Covid-19 vaccine trials.

In a press release, Pfizer Senior Vice President and Head of Vaccine Research & Development, Dr Kathrin Jansen said:

‘We are dedicated to develop potentially groundbreaking vaccines and medicines, and in the face of this global health crisis, we approach this goal with the utmost urgency. We look forward to publishing our clinical data in a peer-reviewed journal as quickly as possible.’

Pfizer finished out the session up 3.21% at US$33.74 per share.

Covid-19 cases continue to rise, Dow Jones futures soft

Though the prospect of a coronavirus vaccine represents a distinct positives, cases of the virus continue to spread across the US at a rapid rate.

Indeed, vaccine or no vaccine, Covid-19 cases continue to climb in a number of key US states, with IG’s Market Analyst, Kyle Rodda saying:

‘The rate of new cases leapt 1.8 per cent across the US, with the state of California, and the state of Arizona reporting their highest daily jump in coronavirus cases since the pandemic began, and the state of Texas reporting its highest ever active case numbers.’

Regardless of that, as of 10:03PM (New York time), Down Jones futures were trading up 23 points or 0.09%, implying the key US benchmark would open in positive territory on Thursday.

Elsewhere, on Thursday a deluge of employment data is set to be released, including: nonfarm payrolls data, unemployment rate data, average hour earnings data, as well as initial and continuing jobless claims data.

Want to trade US futures – long or short?

Create an IG trading account or log in to your existing account to get started now.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access
Learn more

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

<h3>How much does trading cost?</h3>
<h3>Find out about IG</h3>
<h3>Plan your trading</h3>

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.